6Carreras E,Bertz H,Arcese W,et al.Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation:a prospective cohort study of the European group for blood and marrow transplantation[ J].Blood,1998,10(2):3599 -604.
7Bearman S L.The syndrome of hepatic veno-occlusive disease after marrow transplantation[ J ].Blood,1995,85:3005 -20.
8Lee JH,Choi SJ,Lee JH,et al.VOD Decreased incidence of hepatic veno-occlusive disease and fewer hemostatic derangements associated with intravenous Busulfan vs oral Busulfan in adults conditioned with Busulfan + cyclophosphamide for allogeneic bone marrow transplantation[ J ].Ann Hematol,2005,84(5):321-30.
9Je-Hwan Lee,Kyoo-Hyung Lee,Jung-Hee Lee,et al.Plasminogen activator inhibitor-1 is an independent diagnostic marker as well as severity predictor of hepatic veno-occlusive disease after allogeneic bone marrow transplantation in adults conditioned with busulphan and cyclophosphamide[ J ].British Journal of Haematology,2002,118 (6):1087 -94.
10Satori MT,Spiezia L,Cesaro S,et al.Role of fibrinolytic and clotting parameters in the diagnosis of liver veno-occlusive disease after hematopoietic stem cell transplantation in a pediatric population[ J ].Thromb Haemost,2005,93 (4):682-9.
